The study demonstrated for the first time a significant correlation between the CDX2 polymorphism and pediatric ITP risk, showing that the GG genotype increased susceptibility, while the A allele conferred protective effects. The gene discussed is CDX2; the disease is autoimmune thrombocytopenic purpura.